Excerpted from AVAC Report: HIV Prevention on the Line, this update details attempts to test vaccine strategy which showed promise in the RV144 trial.
Intervention Update: What’s Next for AIDS Vaccines and the P5 Partnership?
Mind the Gap
This graphic, presented in the AVAC Report 2014/15: HIV Prevention on the Line, shows all the components of a comprehensive response to end the epidemic.
Targets that Worked
As seen in this graphic from AVAC Report 2014/15: HIV Prevention on the Line, ambitious coverage targets that are well-defined in terms of the components of service delivery, impact and populations and need led to success for VMMC (VMMC) and antiretroviral therapy (ART).
A Target That Worked: 3 by 5
Appearing in AVAC Report 2014/2015: HIV Prevention on the Line, this graphic shows how a target was set and met to provide ART Treatment U=U to 3 million people.
New HIV Infections in Low-and Middle-Income Countries by Scenario
Appearing in the AVAC Report 2014/15: HIV Prevention on the Line, this graphic illustrates how different combinations of interventions affect rates of HIV acquisition.
Targets that Require Work: PrEP and Combination Prevention
Targets are urgently needed for daily oral PrEP and combination prevention. This graphic, from AVAC Report 2014/15: HIV Prevention on the Line, proposes goals and shows what’s in place and what is missing today.
Past Success, Present Gaps: VMMC targets, 2011 and today
VMMC (VMMC) is a highly effective HIV prevention strategy that has benefited from ambitious target setting that ticked all the boxes—investment, political will and evidence. This graphic is from AVAC Report 2014/15: HIV Prevention on the Line.
AVAC Report 2014/15: Prevention on the Line [Executive Summary]
This executive summary, excerpted from AVAC Report 2014/15, puts the current discussion about global targets for ending AIDS in context. What makes a good target? What targets have worked in the past—and why? What is the state of HIV prevention targets and plans today?
Essential Actions for HIV Prevention Research Rollout 2014/15
This updated version of AVAC’s 3D graphic shows priorities across the research-to-rollout spectrum. The graphic appears in AVAC Report 2014/15: Prevention on the Line.
What do women want in multipurpose technologies?
Multipurpose Prevention Technologies (MPTs) are a fast-growing area in women’s sexual and reproductive health. On November 12, AVAC and CAMI Health co-hosted a webinar: MPT Acceptability in Uganda, Nigeria and South Africa.